Teriflunomide
RxNorm 1310520
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1310520 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: teriflunomide.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing teriflunomide (medicinal product)
(Atom ID: 9263176)
INPrescribable
Ingredient (IN):
Teriflunomide
(Atom ID: 4660308)
PTPrescribable
Designated preferred name (PT):
Teriflunomide
(Atom ID: 6389911)
FNPrescribable
Full form of descriptor (FN):
Teriflunomide (substance)
(Atom ID: 6389914)
PTPrescribable
Designated preferred name (PT):
Teriflunomide-containing product
(Atom ID: 10821646)
Patient Education
Teriflunomide
Teriflunomide is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Teriflunomide is in a class of medications called immunomodulatory agents. It is thought to work by decreasing inflammation and decreasing the action of immune cells that may cause nerve damage.
[Learn More]
* Please review the disclaimer below.